Previous Close | 0.0100 |
Open | 0.0100 |
Bid | 0.0000 |
Ask | 0.0200 |
Strike | 70.00 |
Expire Date | 2024-06-21 |
Day's Range | 0.0100 - 0.0100 |
Contract Range | N/A |
Volume | |
Open Interest | 1.9k |
Andrew Baum, the prominent Wall Street drug company analyst will be the pharma firm’s chief strategy and innovation officer.
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The pharmaceutical company posts a first-quarter loss of €1.31 a share, a swing from year-earlier profit of €2.05.